Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05850247Phase 2Recruiting
Phase 2, open-label, single-arm trial, sponsored by Hospices Civils de Lyon. Primary endpoint: Correlation between Plasma levels of ficolin-2 and Metabolic data on [18F]DPA-714 PET/MRI at Day 5. Started Feb 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05850247.